AJP - Heart AJP: Lung Cellular and Molecular Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Am J Physiol Heart Circ Physiol (March 21, 2008). doi:10.1152/ajpheart.00175.2008
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
294/5/H2242    most recent
00175.2008v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Web of Science (9)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Trask, A. J.
Right arrow Articles by Ferrario, C. M
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Trask, A. J.
Right arrow Articles by Ferrario, C. M
Submitted on February 17, 2008
Accepted on March 13, 2008

Angiotensin-(1-12) is an Alternate Substrate for Angiotensin Peptide Production in the Heart

Aaron J. Trask1*, Jewell A Jessup1, Mark C. Chappell1, and Carlos M Ferrario1

1 Wake Forest University School of Medicine

* To whom correspondence should be addressed. E-mail: atrask{at}wfubmc.edu.

Identification of angiotensin-(1-12) as an intermediate precursor derived directly from angiotensinogen led us to explore whether the heart has the capacity to process angiotensin-(1-12) into the biologically-active angiotensin peptides. The generation of angiotensin I, angiotensin II, and angiotensin-(1-7) from exogenous angiotensin-(1-12) was evaluated in the effluent of isolated perfused hearts mounted on a Langendorff apparatus in three normotensive and two hypertensive strains - the Sprague-Dawley, Lewis, congenic mRen2.Lewis, Wistar-Kyoto, and Spontaneously Hypertensive rats. Hearts were perfused with Krebs solution for 60 minutes before and after the addition of angiotensin-(1-12) (10 nmol/L). Angiotensin-(1-12) caused the rapid appearance of both angiotensin I and angiotensin II in the perfusate that peaked between 30 and 60 minutes of recirculation. Production of angiotensin-(1-7) from exogenous angiotensin-(1-12) rose steadily over the course of the 60-minute experiment. These data directly demonstrate that angiotensin-(1-12) is a substrate for the formation of angiotensin peptides in cardiac tissue. This finding further suggests that this angiotensinogen-derived product is a previously unrecognized important precursor peptide to the renin-angiotensin system cascade.




This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
E. Lazartigues
A map and new directions for the (pro)renin receptor in the brain: focus on "A role of the (pro)renin receptor in neuronal cell differentiation"
Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2009; 297(2): R248 - R249.
[Full Text] [PDF]


Home page
Am. J. Physiol. Gastrointest. Liver Physiol.Home page
C. B. Herath, J. S. Lubel, Z. Jia, E. Velkoska, D. Casley, L. Brown, C. Tikellis, L. M. Burrell, and P. W. Angus
Portal pressure responses and angiotensin peptide production in rat liver are determined by relative activity of ACE and ACE2
Am J Physiol Gastrointest Liver Physiol, July 1, 2009; 297(1): G98 - G106.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
K. Isa, M. A. Garcia-Espinosa, A. C. Arnold, N. T. Pirro, E. N. Tommasi, D. Ganten, M. C. Chappell, C. M. Ferrario, and D. I. Diz
Chronic immunoneutralization of brain angiotensin-(1-12) lowers blood pressure in transgenic (mRen2)27 hypertensive rats
Am J Physiol Regulatory Integrative Comp Physiol, July 1, 2009; 297(1): R111 - R115.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
P. M. Cummins
A new addition to the renin-angiotensin peptide family: proAngiotensin-12 (PA12)
Cardiovasc Res, April 1, 2009; 82(1): 7 - 8.
[Full Text] [PDF]


Home page
Am. J. Physiol. Heart Circ. Physiol.Home page
C. M. Ferrario, J. Varagic, J. Habibi, S. Nagata, J. Kato, M. C. Chappell, A. J. Trask, K. Kitamura, A. Whaley-Connell, and J. R. Sowers
Differential regulation of angiotensin-(1-12) in plasma and cardiac tissue in response to bilateral nephrectomy
Am J Physiol Heart Circ Physiol, April 1, 2009; 296(4): H1184 - H1192.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
H. C.G. Prosser, M. E. Forster, A. M. Richards, and C. J. Pemberton
Cardiac chymase converts rat proAngiotensin-12 (PA12) to angiotensin II: effects of PA12 upon cardiac haemodynamics
Cardiovasc Res, April 1, 2009; 82(1): 40 - 50.
[Abstract] [Full Text] [PDF]


Home page
Mol. Interv.Home page
D. I. Diz
Future Directions in Cardiovascular Pharmacology: Examples from the Renin-Angiotensin System
Mol. Interv., October 1, 2008; 8(5): 222 - 225.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 1977 by the American Physiological Society.